Revenue by product segment and geography Revenue grew from DKK 115.6 million to DKK 124.6 million in Q1 2025/26, a year-on-year increase of 8% that was driven by higher sales of instruments, ...
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first nine months (Q3) of 2025 in the morning on Thursday, 13 November 2025.
EssilorLuxottica étend sa plateforme de solutions de gestion de la myopie avec les verres Essilor Stellest 2.0, des lunettes connectées et une solution innovante pour adresser la pré-myopie ...
Compelling kidney function data from VIVIAD Phase 2b study presented in late-breaking poster at ASN kidney week, the world’s premier nephrology meeting VIVIAD analyses continue to support ...
The portal gives customers instant access to both their online and offline purchases and enables them to reorder products directly from any previous order with just one click. By digitizing offline ...
Post procedure mean minimum stent area (MSA) was 6.89 mm², exceeding the powered performance goal (PG) of 4.9 mm² (p < 0.0001), derived from previous IVL and rotational atherectomy device studies ...
Information relative au nombre total de droits de vote et d’actions composant le capital social ...
Novo Nordisk currently expects an estimated negative low single-digit impact on global sales growth in 2026 ...
Channel Medsystems, a commercial-stage women’s health company, announced today that more than 5,000 women have now been treated with the Cerene® Cryotherapy Device, underscoring the growing clinical ...
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution ...
Bilateral kidney injection with rilparencel resulted in a 4.6 mL/min/1.73m2 (78%) improvement in the annual decline of estimated glomerular filtration rate (eGFR) slope in Group 1 (n=24) patients No ...
November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025. Highlights. Announcement of Genmab’s proposed acquisition of Merus N.V. (Merus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback